Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tianeptine Sodium Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115872951A reveals a novel base-catalyzed route for high-purity tianeptine intermediates, offering significant cost reduction and supply chain reliability.
Patent CN105254587A details a safer chlorination route for tianeptine sodium intermediate using industrial hydrochloric acid, ensuring high purity and supply chain stability.
Patent CN110172045B reveals a green synthesis route for tianeptine sodium intermediates using fixed-bed oxidation, offering significant cost reduction and supply chain stability for API manufacturers.